Publications of C. Griesinger
All genres
Conference Paper (17)
301.
Conference Paper
21 (Suppl. 1), p. 170 - 170 (2014)
The oligomer modulator anle138b is effective in the prodromal phase of a transgenic mouse model of Parkinson's disease. Joint Congress of European Neurology, Istanbul, Turkey, May 31, 2014 - June 03, 2014. European Journal of Neurology 302.
Conference Paper
42 (Supplement 1), p. S204 - S204 (2013)
Structure of a bacterial filament solved by solid-state NMRa: The type III secretion system needle. 9th European-Biophysical-Societies-Association Congress, Lissabon/Portugal, July 13, 2013 - July 17, 2013. European Biophysics Journal with Biophysics Letters 303.
Conference Paper
104 (Supplement 1), 2 Ed., p. 30A - 30A (2013)
Molecular recognition through concerted ubiquitin backbone and side chain motion determined from NMR and MD simulations. 57th Annual Meeting of the Biophysical-Society, Philadelphia/PA, February 02, 2013 - February 06, 2013. Biophysical Journal 304.
Conference Paper
104 (Supplement 1), 2 Ed., p. 30A - 30A (2013)
Molecular Recognition through Concerted Ubiquitin Backbone and Side Chain Motion Determined from NMR and MD Simulations. 57th Annual Meeting of the Biophysical-Society, Philadelphia, February 02, 2013 - February 06, 2013. Biophysical Journal 305.
Conference Paper
70 (6), p. 505 - 505 (2011)
Causal therapy of prion and Parkinson's disease with novel inhibitors of protein aggregation. 87th Annual Meeting of the American Association of Neuropathologists, Seattle, WA, June 23, 2011 - June 26, 2011. Journal of Neuropathology and Experimental Neurology 306.
Conference Paper
26 (Supplement 2), p. S21 - S21 (2011)
Causal therapy of Parkinson's disease with anle138b, a novel protein aggregation inhibitor. 15th International Congress of Parkinsons Disease and Movement Disorders, Toronto, CANADA, 2011. Movement Disorders 307.
Conference Paper
88 (1), p. 396A - 396A (2005)
3D structure, ligand binding, autoinhibition, aggregation, and cellular distribution of wild-type, mutant, and labeled alpha-synuclein. Biophysical Journal Meeting Abstract (7)
308.
Meeting Abstract
279 (Supplement 1), pp. 1 - 2. 22nd IUBMB Congress/37th FEBS Congress, Seville/Spain, September 04, 2012 - September 09, 2012. (2012)
Fuzzyness of globular and aggregating proteins in neurodegeneration: an NMR spectroscopic view. In FEBS Journal, 309.
Meeting Abstract
279 (Suppl. 1), P20-86, p. 433 - 433. 22nd IUBMB Congress/37th FEBS Congress, Seville/Spain, September 04, 2012 - September 09, 2012. (2012)
Functional dynamics in the voltage-dependent anion channel. In FEBS Journal, 310.
Meeting Abstract
21 (Supplement 1), p. 96 - 96. 26th Annual Symposium of the Protein-Society, San Diego, CA, August 05, 2012 - August 08, 2012. (2012)
Exceeding the limit of dynamics studies on proteins using NMR spectroscopy. In Protein Science, 311.
Meeting Abstract
21 (Supplement 1), p. 146 - 146. 26th Annual Symposium of the Protein-Society, San Diego, CA, August 05, 2012 - August 08, 2012. (2012)
Measuring the kinetics of conformational sampling during binding with NMR spectroscopy. In Protein Scinece, 312.
Meeting Abstract
78 11 Ed., p. 1278 - 1278. International Congress on Natural Products Research on Global Change, Natural Products and Human Health/8th Joint Meeting of AFERP, ASP, GA, PSE and SIF , New York/USA, July 28, 2012 - August 01, 2012. (2012)
Synergistic trail sensitizers from Barleria alluaudii and Diospyros maritima. In Planta Medica, 313.
Meeting Abstract
21 (Supplement 1), p. 190 - 190. 26th Annual Symposium of the Protein-Society, San Diego; CA, August 05, 2012 - August 08, 2012. (2012)
Direct observation of correlated protein motions detected by NMR spectroscopy. In Protein Science, 314.
Meeting Abstract
21 (Supplement 1), pp. 209 - 210. 26th Annual Symposium of the Protein-Society, San Diego; CA, August 05, 2012 - August 08, 2012. (2012)
N-glycan recognition by the cyanobacterial Oscillatoria aghardii lectin. In Protein Science, Other (1)
315.
Other
Paramagnetic lanthanide tagging for NMR conformational analyses of N-linked oligosaccharides, Chemistry-A European Journal 17, pp. 9280 - 9282 (2011)
Patent (2)
316.
Patent
Mutant alpha-synuclein with increased toxicity. WO/2010/015714 (2010)
317.
Patent
New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases. WO/2010/00372 (2010)